Evidence map›Paper›PMID 42667681›Full record

ArticleInternational journal of epidemiology2026

Negative controls and how to use them: a guidance paper.

Sophie H Bots, Anna Schultze, Romin Pajouheshnia, Ian J Douglas, Rosa Gini, Olaf H Klungel, Rolf H H Groenwold

Abstract read
In one paragraph

Article in International journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sophie H BotsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-4483-5582
Anna SchultzeFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Romin PajouheshniaDepartment of Epidemiology, RTI-Health Solutions, Barcelona, Spain.
Ian J DouglasFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Rosa GiniARS Toscana, Florence, Italy.
Olaf H KlungelDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-5604-813X
Rolf H H GroenwoldDepartment of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0001-9238-6999

Funding

Ministry of Education, Culture and Science of the NetherlandsSector Plan Pharmaceutical Sciences
6 · The paper itself

Abstract

Negative controls have gained traction as a useful tool for causal research to address confounding and bias. However, general guidance on how to select and apply negative controls and how to report and interpret their findings is lacking. This paper lays out the key steps of conducting a negative-control analysis and provides all relevant background information, important feasibility and validity considerations, and practical suggestions for the implementation and interpretation of each step. This includes a convenient overview of all methods, complete with their rationale, key considerations, and illustrative examples, and practical checklists that both researchers and reviewers can use to facilitate the complete and rigorous reporting of negative-control analyses.

Indexed as

Research DesignBiasConfounding Factors, EpidemiologicHumansbiasconfoundingmethodologynegative controls

Identifiers

PMID42667681
PMCPMC13525841

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.